No takes yet. Share an insight, caveat, or question.
Randomized trial demonstrated that connexin and A-CAM antibodies inhibit junction formation, implying a critical role for these proteins.
Meyer et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: